Loading
HOXA9 is an embryonic growth gene that some leukaemias keep switched on so their cells never mature. Menin inhibitors such as revumenib and ziftomenib do not touch HOXA9 itself; they pull menin off the DNA so the gene switches off and the cells grow up. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
HOXA9 is not directly druggable in the corpus; the menin inhibitors act on the scaffold that keeps it expressed, and MEIS1 is its cofactor in the same programme (UniProt O00470).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
No recorded escape route names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"HOXA9" OR ABSTRACT:"HOXA9" OR TITLE:"HOX1G" OR ABSTRACT:"HOX1G" OR TITLE:"HOX1" OR ABSTRACT:"HOX1" OR TITLE:"homeobox A9" OR ABSTRACT:"homeobox A9") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about HOXA9, not a curated reading list.
The dossier as machine-readable JSON, at /api/v1/dossiers/hoxa9.json: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/hoxa9.json. Licence CC BY-NC 4.0.